dc.contributor.author |
Tsutsui A. |
|
dc.contributor.author |
Pradipta A. |
|
dc.contributor.author |
Saigitbatalova E. |
|
dc.contributor.author |
Kurbangalieva A. |
|
dc.contributor.author |
Tanaka K. |
|
dc.date.accessioned |
2018-09-18T20:45:38Z |
|
dc.date.available |
2018-09-18T20:45:38Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
2040-2503 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/142275 |
|
dc.description.abstract |
© 2015 The Royal Society of Chemistry. We synthetically demonstrate that eight-membered heterocycles, namely, 2,6,9-triazabicyclo[3.3.1]nonanes and 1,5-diazacyclooctanes, are the exclusive products of the reaction of acrolein with biologically relevant amines via an imino[4 + 4]cycloaddition. These compounds are produced in much higher amounts and efficiencies than the acrolein biomarker in current use, 3-formyl-3,4-dehydropiperidine (FDP). Our results not only indicate that eight-membered heterocycles may potentially be used as new biomarkers, but also strongly suggest the involvement of these heterocycles in various important biological phenomena, e.g., an acrolein-mediated mechanism underlying oxidative stress. |
|
dc.relation.ispartofseries |
MedChemComm |
|
dc.title |
Exclusive formation of imino[4 + 4]cycloaddition products with biologically relevant amines: Plausible candidates for acrolein biomarkers and biofunctional modulators |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
3 |
|
dc.relation.ispartofseries-volume |
6 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
431 |
|
dc.source.id |
SCOPUS20402503-2015-6-3-SID84924428149 |
|